462 related articles for article (PubMed ID: 27248175)
1. Targeting folate receptor alpha for cancer treatment.
Cheung A; Bax HJ; Josephs DH; Ilieva KM; Pellizzari G; Opzoomer J; Bloomfield J; Fittall M; Grigoriadis A; Figini M; Canevari S; Spicer JF; Tutt AN; Karagiannis SN
Oncotarget; 2016 Aug; 7(32):52553-52574. PubMed ID: 27248175
[TBL] [Abstract][Full Text] [Related]
2. Exploiting the folate receptor α in oncology.
Scaranti M; Cojocaru E; Banerjee S; Banerji U
Nat Rev Clin Oncol; 2020 Jun; 17(6):349-359. PubMed ID: 32152484
[TBL] [Abstract][Full Text] [Related]
3. Folate Receptor α-Targeted
Heo GS; Detering L; Luehmann HP; Primeau T; Lee YS; Laforest R; Li S; Stec J; Lim KH; Lockhart AC; Liu Y
Mol Pharm; 2019 Sep; 16(9):3996-4006. PubMed ID: 31369274
[TBL] [Abstract][Full Text] [Related]
4. Folate-targeted immunotherapies: Passive and active strategies for cancer.
Farran B; Pavitra E; Kasa P; Peela S; Rama Raju GS; Nagaraju GP
Cytokine Growth Factor Rev; 2019 Feb; 45():45-52. PubMed ID: 30770191
[TBL] [Abstract][Full Text] [Related]
5. High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation.
Nunez MI; Behrens C; Woods DM; Lin H; Suraokar M; Kadara H; Hofstetter W; Kalhor N; Lee JJ; Franklin W; Stewart DJ; Wistuba II
J Thorac Oncol; 2012 May; 7(5):833-40. PubMed ID: 22729036
[TBL] [Abstract][Full Text] [Related]
6. IMGN853, a Folate Receptor-α (FRα)-Targeting Antibody-Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FRα-Expressing Tumors.
Ab O; Whiteman KR; Bartle LM; Sun X; Singh R; Tavares D; LaBelle A; Payne G; Lutz RJ; Pinkas J; Goldmacher VS; Chittenden T; Lambert JM
Mol Cancer Ther; 2015 Jul; 14(7):1605-13. PubMed ID: 25904506
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy targeting folate receptor induces cell death associated with autophagy in ovarian cancer.
Wen Y; Graybill WS; Previs RA; Hu W; Ivan C; Mangala LS; Zand B; Nick AM; Jennings NB; Dalton HJ; Sehgal V; Ram P; Lee JS; Vivas-Mejia PE; Coleman RL; Sood AK
Clin Cancer Res; 2015 Jan; 21(2):448-59. PubMed ID: 25416196
[TBL] [Abstract][Full Text] [Related]
8. Modification of cytokine-induced killer cells with folate receptor alpha (FRα)-specific chimeric antigen receptors enhances their antitumor immunity toward FRα-positive ovarian cancers.
Zuo S; Wen Y; Panha H; Dai G; Wang L; Ren X; Fu K
Mol Immunol; 2017 May; 85():293-304. PubMed ID: 28360017
[TBL] [Abstract][Full Text] [Related]
9. Paradoxical impact of two folate receptors, FRα and RFC, in ovarian cancer: effect on cell proliferation, invasion and clinical outcome.
Siu MK; Kong DS; Chan HY; Wong ES; Ip PP; Jiang L; Ngan HY; Le XF; Cheung AN
PLoS One; 2012; 7(11):e47201. PubMed ID: 23144806
[TBL] [Abstract][Full Text] [Related]
10. Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes.
Bax HJ; Chauhan J; Stavraka C; Santaolalla A; Osborn G; Khiabany A; Grandits M; López-Abente J; Palhares LCGF; Chan Wah Hak C; Robinson A; Pope A; Woodman N; Naceur-Lombardelli C; Malas S; Coumbe JEM; Nakamura M; Laddach R; Mele S; Crescioli S; Black AM; Lombardi S; Canevari S; Figini M; Sayasneh A; Tsoka S; FitzGerald K; Gillett C; Pinder S; Van Hemelrijck M; Kristeleit R; Ghosh S; Montes A; Spicer J; Karagiannis SN; Josephs DH
Br J Cancer; 2023 Jan; 128(2):342-353. PubMed ID: 36402875
[TBL] [Abstract][Full Text] [Related]
11. Folate receptor alpha antagonists in preclinical and early stage clinical development for the treatment of epithelial ovarian cancer.
Bergamini A; Ferrero S; Leone Roberti Maggiore U; Scala C; Pella F; Vellone VG; Petrone M; Rabaiotti E; Cioffi R; Candiani M; Mangili G
Expert Opin Investig Drugs; 2016 Dec; 25(12):1405-1412. PubMed ID: 27797594
[TBL] [Abstract][Full Text] [Related]
12. Correlation of folate receptor alpha expression with clinicopathological parameters and outcome in triple negative breast cancer.
Zagorac I; Lončar B; Dmitrović B; Kralik K; Kovačević A
Ann Diagn Pathol; 2020 Oct; 48():151596. PubMed ID: 32829070
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional insights on folate receptor α (FRα) by homology modeling, ligand docking and molecular dynamics.
Della-Longa S; Arcovito A
J Mol Graph Model; 2013 Jul; 44():197-207. PubMed ID: 23880302
[TBL] [Abstract][Full Text] [Related]
14. High expression of folate receptor alpha is associated with poor prognosis in patients with cervical cancer.
Yazaki S; Kojima Y; Yoshida H; Takamizawa S; Kitadai R; Nishikawa T; Shimoi T; Sudo K; Saito A; Okuma HS; Tanioka M; Noguchi E; Uno M; Ishikawa M; Kato T; Fujiwara Y; Ohe Y; Yonemori K
J Gynecol Oncol; 2022 Nov; 33(6):e82. PubMed ID: 36245230
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic strategies targeting folate receptor α for ovarian cancer.
Mai J; Wu L; Yang L; Sun T; Liu X; Yin R; Jiang Y; Li J; Li Q
Front Immunol; 2023; 14():1254532. PubMed ID: 37711615
[TBL] [Abstract][Full Text] [Related]
16. Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRα-targeting antibody-drug conjugate mirvetuximab soravtansine.
Martin LP; Konner JA; Moore KN; Seward SM; Matulonis UA; Perez RP; Su Y; Berkenblit A; Ruiz-Soto R; Birrer MJ
Gynecol Oncol; 2017 Nov; 147(2):402-407. PubMed ID: 28843653
[TBL] [Abstract][Full Text] [Related]
17. Detecting Functional and Accessible Folate Receptor Expression in Cancer and Polycystic Kidneys.
Chu H; Shillingford JM; Reddy JA; Westrick E; Nelson M; Wang EZ; Parker N; Felten AE; Vaughn JF; Xu LC; Lu YJ; Vlahov IR; Leamon CP
Mol Pharm; 2019 Sep; 16(9):3985-3995. PubMed ID: 31356752
[TBL] [Abstract][Full Text] [Related]
18. A T-cell engaging bispecific antibody with a tumor-selective bivalent folate receptor alpha binding arm for the treatment of ovarian cancer.
Avanzino BC; Prabhakar K; Dalvi P; Hartstein S; Kehm H; Balasubramani A; Boudreau AA; Buelow B; Chang K; Davison LM; Iyer S; Kalwit V; Lewis Wilson K; Malik-Chaudhry HK; Pierson W; Pineda G; Rangaswamy US; Saiganesh S; Schellenberger U; Ugamraj HS; Yabut RD; Buelow R; Chapman J; Trinklein ND; Harris KE
Oncoimmunology; 2022; 11(1):2113697. PubMed ID: 36016696
[TBL] [Abstract][Full Text] [Related]
19. Protein-Labeling Fluorescent Probe for Folate Receptor α.
Fang PW; Lin YC; Fan SY; Panja A; Xu SQ; Lee SH; Tan KT
Anal Chem; 2023 Aug; 95(30):11535-11541. PubMed ID: 37479992
[TBL] [Abstract][Full Text] [Related]
20. Super-resolution imaging of folate receptor alpha on cell membranes using peptide-based probes.
Jing Y; Huang L; Dong Z; Gong Z; Yu B; Lin D; Qu J
Talanta; 2024 Feb; 268(Pt 1):125286. PubMed ID: 37832456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
